日本語 / English

NEW　Special edition for CBI2018 Sponsored Sessions with inviting key speakers from in-silico and iPS drug discovery.

NEW　Special page for Japanese business development for non-Japanese start-up companies.

Biospire is a technology management consultancy. We specialise in working with early stage technology projects including those developed within academic environments. Biospire provides support and development services to a variety of clients including university technology transfer offices, research councils, large corporates, technology-based SMEs, and partnering work with other specialist consultancies.

Biospire provides a range of services in early stage technology management from technical and commercial project evaluation, to development of new spin-out companies, through to supporting corporates with technology sourcing or business development in new territories. We concentrate on the life sciences, but also have a successful track record in working in other technology areas including advanced materials, telecoms, and environmental technologies. 

We specialise in the transfer and development of technologies and business between European and Asian markets and have active networks across Europe, China, Hong Kong, Singapore and Taiwan. Our founding consultants have extensive practical experience in academic and commercial environments, both within SMEs and large multinational technology businesses. We focus on delivering practical, bottom-line value to our clients, which is milestone-based, providing solutions and step-changes for developing technologies and businesses. Biospire has a presence in Oxford, UK and Kyoto, Japan. These two academically and historically rich cities provide a useful focus for our business and we have extensive academic and commercial networks in both regions. 

Our mission is to utilise our European-Asian expertise to deliver high value, bespoke, and personal early stage technology management support.

- Biospire Mission Statement -

"Create new drug discovery platform with having fusion and synergy with gathering top scientific IT and iPS drug discovery technology from the world." 

Centralise technical platform and information